background image

Paid Clinical Trials Hialeah

Discover 1,806 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Miami FL, Atlanta GA, Charlotte NC, Winston-Salem NCshow 8 more

Code:

NCT04064827

Conditions

Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism (SHPT)

Eligibility Criteria

Sex: All

Age: 0 - 9

Healthy Volunteers: Not accepted

Interventions

Paricalcitol

Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation

Recruiting

Sponsor:

University of Miami

Location:

Miami FL

Code:

NCT05890027

Conditions

Ptosis, Eyelid

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Phenylephrine Ophthalmic

Eyelid Tape

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Miami FL, Coral Gables FL, Aventura FL, Coral Springs FLshow 6 more

Code:

NCT06311227

Conditions

Recurrent Hairy Cell Leukemia

Recurrent Hairy Cell Leukemia Variant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

VENOUS: A Translational Study of Enterococcal Bacteremia

Recruiting

Sponsor:

The University of Texas Health Science Center, Houston

Location:

Miami FL, Chapel Hill NC, Jackson MS, Houston TXshow 3 more

Code:

NCT04410276

Conditions

Enterococcal Bacteremia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting
PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Miami FL, Orlando FL, Bay Pines FL, Charleston SCshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting
PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Miami FL, Ocoee FL, Inverness FL, Ocala FLshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Recruiting
PHASE3

Sponsor:

RayzeBio, Inc.

Location:

Miami FL, Tampa FL, Jacksonville FL, Atlanta GAshow 28 more

Code:

NCT05477576

Conditions

GEP-NET

Gastroenteropancreatic Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor Disease

Neuroendocrine Tumors

Carcinoid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

Everolimus

Sunitinib

Octreotide

Lanreotide

Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting
PHASE2
PHASE3

Sponsor:

Emory University

Location:

Miami FL, Jacksonville FL, Atlanta GA, Greenville SCshow 32 more

Code:

NCT04167527

Conditions

Cerebral Ischemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device

Initial medical management (iMM)

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Miami FL, Hollywood FL, Orlando FL, Chapel Hill NCshow 10 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Hialeah FL, Miami FL, Aventura FL, Margate FLshow 76 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo